307 related articles for article (PubMed ID: 27682867)
1. Natural Products as a Source for Antileishmanial and Antitrypanosomal Agents.
Scotti MT; Scotti L; Ishiki H; Ribeiro FF; Cruz RM; Oliveira MP; Mendonça FJ
Comb Chem High Throughput Screen; 2016; 19(7):537-53. PubMed ID: 27682867
[TBL] [Abstract][Full Text] [Related]
2. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
3. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
Orosco D; Mendoza AR; Meléndez CM
Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
[TBL] [Abstract][Full Text] [Related]
5. Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives.
Elawad MA; Elkhalifa MEM; Hamdoon AAE; Salim LHM; Ahmad Z; Ayaz M
Steroids; 2023 May; 193():109196. PubMed ID: 36764565
[TBL] [Abstract][Full Text] [Related]
6. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
7. Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis.
Salem MM; Werbovetz KA
Curr Med Chem; 2006; 13(21):2571-98. PubMed ID: 17017912
[TBL] [Abstract][Full Text] [Related]
8. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
9. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
[TBL] [Abstract][Full Text] [Related]
10. Drug design for neglected disease in Brazil.
Giarolla J; Ferreira EI
Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
[TBL] [Abstract][Full Text] [Related]
11. Manzamine alkaloids as antileishmanial agents: A review.
Ashok P; Lathiya H; Murugesan S
Eur J Med Chem; 2015 Jun; 97():928-36. PubMed ID: 25023608
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
13. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
14. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
15. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
Ogungbe IV; Setzer WN
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775577
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
Pone BK; Ferreira EI
Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
[TBL] [Abstract][Full Text] [Related]
17. An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae.
Koko WS; Al Nasr IS; Khan TA; Schobert R; Biersack B
Chem Biodivers; 2022 Jan; 19(1):e202100542. PubMed ID: 34822224
[TBL] [Abstract][Full Text] [Related]
18. The Role of Nitro (NO
Kamdem BP; Elizabeth FI
Curr Drug Targets; 2021; 22(4):379-398. PubMed ID: 33371845
[TBL] [Abstract][Full Text] [Related]
19. Macrocycles as potential therapeutic agents in neglected diseases.
Peña S; Scarone L; Serra G
Future Med Chem; 2015; 7(3):355-82. PubMed ID: 25650721
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the fight against leishmaniasis with natural products.
Akendengue B; Ngou-Milama E; Laurens A; Hocquemiller R
Parasite; 1999 Mar; 6(1):3-8. PubMed ID: 10229931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
